Related Experiment Video
Updated: Jul 10, 2025

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
[Management of membranoproliferative glomerulonephritis secondary to infection by hepatitis C virus]
Ignacio Lasierra Lavilla1, Amalia Perona Caro2, Celia Del Agua Arias-Camisón3
1Servicio Aragonés de Salud. Hospital. Hospital Obispo Polanco. Servicio de Medicina Interna. Teruel. España.. ilasierral@gmail.com.
Abstract:
Membranoproliferative glomerulonephritis is an uncommon condition that affects the glomeruli of the kidneys; its prevalence has decreased in our environment. Membranoproliferative glomerulonephritis has a characteristic histology that can be associated to different diseases. The clinical presentation varies, and to achieve a definitive diagnosis a renal biopsy must be done. Treatment is based on the underlying disease; when a drop in glomerular filtration rate is detected, immunosuppressants are prescribed. We describe the management of a 47-year-old female with membranoproliferative glomerulonephritis secondary to hepatitis C virus infection, a condition with very low prevalence.
Insights
Membranoproliferative glomerulonephritis, a rare kidney disease, often requires a renal biopsy for diagnosis. Treatment focuses on the underlying cause, especially when kidney function declines.
Area of Science:
- Nephrology
- Immunology
- Virology
Background:
- Membranoproliferative glomerulonephritis (MPGN) is an uncommon kidney disease affecting glomeruli.
- Its prevalence is decreasing, and MPGN can be linked to various underlying conditions.
- Diagnosis requires a renal biopsy due to variable clinical presentations.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Acute Pancreatitis II: Clinical Manifestations and Management

